In Brief: Bradley Pharmaceuticals
This article was originally published in The Tan Sheet
Executive Summary
Bradley Pharmaceuticals: Acquires Acid Mantle skin treatment line from Sandoz, Fairfield, N.J.-based Bradley announced May 9. Purchased for less than $1 mil., the line will be marketed by Bradley's Doak Dermatologics subsidiary. Distribution of Acid Mantle with hydrocortisone will begin in the third quarter with accompanying advertising, promotion and sampling efforts. Additional line extensions are planned to follow, the company stated. Other Doak product lines include Carmol body lotions and Formula 405 skin care products...